The SmallCapRelations Newsletter Where Promising Small-cap Market Plays Meet Forward-thinking Investors

The SmallCapRelations Newsletter Newsletter Archives

SmallCapRelationsSpotlight Company

Sigyn Therapeutics Inc. (OTCQB: SIGY)

Investment Considerations Sigyn Therapeutics in May 2023 announced patent and trademark applications for its ImmunePrep commercialization platform. In October 2022, the company announced patent and trademark applications for ChemoPrep and ChemoPure to enhance chemotherapy and reduce toxicity. Sigyn Therapeutics in September 2022 announced plans to conduct first-in-human feasibility studies in end-stage renal disease patients. In … Continue reading “Sigyn Therapeutics Inc. (OTCQB: SIGY)”

View Profile

Sigyn Therapeutics Inc. (OTCQB: SIGY)

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
IBN (InvestorBrandNetwork)

SmallCapRelations is part of the IBN (InvestorBrandNetwork).

SmallCapRelations (SCR) exists to enhance the communication between public entities and stakeholders through accurate, timely and informative messaging solutions. We also specialize in the unique communication needs of private companies planning to go public. With a substantial staff of corporate communication professionals, SCR builds a framework that rapidly conveys your brand's messaging to potential shareholders, clients, analysts, media and the general public.

Other brands within the network include:
CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SeriousTraders
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo